Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Vaxeal Holding SA – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘Vaxeal Holding SA – Product Pipeline Review – 2015’, provides an overview of the Vaxeal Holding SA’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxeal Holding SA’s, complete with comparative analysis at various stages, therapeutics assessment by..

Total Pages: 18

vaxeal-holding-sa-product-pipeline-review-2015
600
#9e2f22

Global Markets Direct’s, ‘Vaxeal Holding SA - Product Pipeline Review - 2015’, provides an overview of the Vaxeal Holding SA’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxeal Holding SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vaxeal Holding SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vaxeal Holding SA’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Vaxeal Holding SA’s pipeline products

Reasons to buy

- Evaluate Vaxeal Holding SA’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vaxeal Holding SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vaxeal Holding SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vaxeal Holding SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vaxeal Holding SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vaxeal Holding SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Vaxeal Holding SA Snapshot 4
Vaxeal Holding SA Overview 4
Key Information 4
Key Facts 4
Vaxeal Holding SA - Research and Development Overview 5
Key Therapeutic Areas 5
Vaxeal Holding SA - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Vaxeal Holding SA - Pipeline Products Glance 9
Vaxeal Holding SA - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Vaxeal Holding SA - Drug Profiles 11
CBX-1 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
SVX-1 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Vaccine for Oncology 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Vaxeal Holding SA - Pipeline Analysis 14
Vaxeal Holding SA - Pipeline Products by Molecule Type 14
Vaxeal Holding SA - Dormant Projects 15
Vaxeal Holding SA - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
Coverage 17
Secondary Research 17
Primary Research 17
Expert Panel Validation 17
Contact Us 17
Disclaimer 18

List of Tables
Vaxeal Holding SA, Key Information 4
Vaxeal Holding SA, Key Facts 4
Vaxeal Holding SA - Pipeline by Indication, 2015 6
Vaxeal Holding SA - Pipeline by Stage of Development, 2015 7
Vaxeal Holding SA - Monotherapy Products in Pipeline, 2015 8
Vaxeal Holding SA - Preclinical, 2015 9
Vaxeal Holding SA - Discovery, 2015 10
Vaxeal Holding SA - Pipeline by Molecule Type, 2015 14
Vaxeal Holding SA - Dormant Developmental Projects,2015 15
Vaxeal Holding SA, Subsidiaries 16

List of Figures
Vaxeal Holding SA - Pipeline by Top 10 Indication, 2015 6
Vaxeal Holding SA - Pipeline by Stage of Development, 2015 7
Vaxeal Holding SA - Monotherapy Products in Pipeline, 2015 8
Vaxeal Holding SA - Pipeline by Top 10 Molecule Type, 2015 14


LICENSE TYPE